HomeFRX • TSE
add
Fennec Pharmaceuticals Inc
Previous close
$9.39
Day range
$9.41 - $9.54
Year range
$9.00 - $15.43
Market cap
259.89M CAD
Avg Volume
2.15K
P/E ratio
190.88
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 25.38M | 1,413.24% |
Operating expense | 11.08M | 61.76% |
Net income | 12.84M | 312.11% |
Net profit margin | 50.59 | 114.02% |
Earnings per share | 0.41 | 235.30% |
EBITDA | 14.47M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 51.18M | 178.33% |
Total assets | 69.19M | 217.09% |
Total liabilities | 66.18M | 126.95% |
Total equity | 3.01M | — |
Shares outstanding | 27.32M | — |
Price to book | 85.36 | — |
Return on assets | 71.54% | — |
Return on capital | 127.93% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 12.84M | 312.11% |
Cash from operations | 39.05M | 800.14% |
Cash from investing | — | — |
Cash from financing | -1.13M | -686.53% |
Net change in cash | 37.92M | 804.22% |
Free cash flow | 8.75M | 344.28% |
About
Founded
1996
Headquarters
Website
Employees
29
